{{knowledge objective
|Identifiant=OIC-316-02-B
|Item_parent=Myelodysplastic syndromes
|Item_parent_short=Myelodysplastic syndromes
|Rank=B
|Title=Knowing the aetiologies of MDS
|Description=15% secondary to toxic exposure (chemotherapy, radiotherapy, ionising radiation, benzene)
|Rubric=Etiologies
|Contributors=
|Order=2}}
Primitive in 85% of cases

They are sometimes secondary

- Chemotherapy:

o Alkylating agents and purine analogues

o Topoisomerase II inhibitors

- Toxic substances: benzene, smoking, solvents

- Ionising radiation

- A acquired haematological diseases: myeloproliferative disorders, bone marrow aplasia and paroxysmal nocturnal haemoglobinuria

- Certain constitutional diseases: trisomy 21, Fanconi anaemia, Kostmann neutropenia, neurofibromatosis, as well as other rare familial genetic diseases predisposing to haemopathies (1/3 of MDS in children).